AIMS/HYPOTHESIS: Neonatal diabetes is a rare disease with several identified molecular aetiologies. Despite associations with other malformations, neonatal diabetes with intestinal and biliary anomalies has not been described. The current study aims to describe a new syndrome, and to examine a possible link with one of three genes known to cause neonatal diabetes. METHODS: Five clinical cases are described. Immunohistochemical staining for pancreatic islet hormones was performed on three of the infants. DNA from one infant was analysed for abnormalities of the PLAGL-1 (ZAC), glucokinase and PDX-1 (IPF-1) genes. RESULTS: Five infants (two sibling pairs from two families, and an isolated case) presented with neonatal diabetes, hypoplastic or annular pancreas, jejunal atresia, duodenal atresia and gall bladder aplasia or hypoaplasia. One sibling pair was born to consanguineous parents. One patient with a milder form is surviving free of insulin. Four children died in the first year of life despite aggressive medical management. Pancreatic immunohistochemistry revealed few scattered chromogranin-A-positive cell clusters but complete absence of insulin, glucagon and somatostatin. Exocrine histology was variable. In one case from the consanguineous family, molecular analysis showed no duplication or uniparental isodisomy of PLAGL-1 at 6q24, no contiguous gene deletion involving the glucokinase gene, and no mutation in the coding sequences or splice sites of PDX-1. CONCLUSIONS/ INTERPRETATION: This combination of multiple congenital abnormalities has not been previously described and probably represents a new autosomal recessive syndrome involving a genetic abnormality that interferes with normal islet development and whose aetiology is as yet unknown.
AIMS/HYPOTHESIS: Neonatal diabetes is a rare disease with several identified molecular aetiologies. Despite associations with other malformations, neonatal diabetes with intestinal and biliary anomalies has not been described. The current study aims to describe a new syndrome, and to examine a possible link with one of three genes known to cause neonatal diabetes. METHODS: Five clinical cases are described. Immunohistochemical staining for pancreatic islet hormones was performed on three of the infants. DNA from one infant was analysed for abnormalities of the PLAGL-1 (ZAC), glucokinase and PDX-1 (IPF-1) genes. RESULTS: Five infants (two sibling pairs from two families, and an isolated case) presented with neonatal diabetes, hypoplastic or annular pancreas, jejunal atresia, duodenal atresia and gall bladder aplasia or hypoaplasia. One sibling pair was born to consanguineous parents. One patient with a milder form is surviving free of insulin. Four children died in the first year of life despite aggressive medical management. Pancreatic immunohistochemistry revealed few scattered chromogranin-A-positive cell clusters but complete absence of insulin, glucagon and somatostatin. Exocrine histology was variable. In one case from the consanguineous family, molecular analysis showed no duplication or uniparental isodisomy of PLAGL-1 at 6q24, no contiguous gene deletion involving the glucokinase gene, and no mutation in the coding sequences or splice sites of PDX-1. CONCLUSIONS/ INTERPRETATION: This combination of multiple congenital abnormalities has not been previously described and probably represents a new autosomal recessive syndrome involving a genetic abnormality that interferes with normal islet development and whose aetiology is as yet unknown.
Authors: A L Gloyn; S Ellard; J P Shield; I K Temple; D J G Mackay; M Polak; T Barrett; A T Hattersley Journal: Diabetologia Date: 2002-02 Impact factor: 10.122
Authors: F Matschinsky; Y Liang; P Kesavan; L Wang; P Froguel; G Velho; D Cohen; M A Permutt; Y Tanizawa; T L Jetton Journal: J Clin Invest Date: 1993-11 Impact factor: 14.808
Authors: Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley Journal: N Engl J Med Date: 2004-04-29 Impact factor: 91.245
Authors: P R Njølstad; O Søvik; A Cuesta-Muñoz; L Bjørkhaug; O Massa; F Barbetti; D E Undlien; C Shiota; M A Magnuson; A Molven; F M Matschinsky; G I Bell Journal: N Engl J Med Date: 2001-05-24 Impact factor: 91.245
Authors: Robert Dankovcik; Jan E Jirasek; Eduard Kucera; Jaroslav Feyereisl; Jozef Radonak; Marek Dudas Journal: Fetal Diagn Ther Date: 2008-12-01 Impact factor: 2.587
Authors: Karilyn E Sant; Haydee M Jacobs; Katrina A Borofski; Jennifer B Moss; Alicia R Timme-Laragy Journal: Environ Pollut Date: 2016-10-31 Impact factor: 8.071
Authors: R Artuso; A Provenzano; B Mazzinghi; L Giunti; V Palazzo; E Andreucci; A Blasetti; R M Chiuri; F E Gianiorio; P Mandich; M Monami; E Mannucci; S Giglio Journal: Pharmacogenomics J Date: 2014-07-22 Impact factor: 3.550
Authors: Stuart B Smith; Hui-Qi Qu; Nadine Taleb; Nina Y Kishimoto; David W Scheel; Yang Lu; Ann-Marie Patch; Rosemary Grabs; Juehu Wang; Francis C Lynn; Takeshi Miyatsuka; John Mitchell; Rina Seerke; Julie Désir; Serge Vanden Eijnden; Marc Abramowicz; Nadine Kacet; Jacques Weill; Marie-Eve Renard; Mattia Gentile; Inger Hansen; Ken Dewar; Andrew T Hattersley; Rennian Wang; Maria E Wilson; Jeffrey D Johnson; Constantin Polychronakos; Michael S German Journal: Nature Date: 2010-02-11 Impact factor: 49.962
Authors: Inas H Thomas; Natinder K Saini; Amita Adhikari; Joyce M Lee; Josephine Z Kasa-Vubu; Delia M Vazquez; Ram K Menon; Ming Chen; Stefan S Fajans Journal: Pediatr Diabetes Date: 2009-06-03 Impact factor: 4.866
Authors: Jason R Spence; Alex W Lange; Suh-Chin J Lin; Klaus H Kaestner; Andrew M Lowy; Injune Kim; Jeffrey A Whitsett; James M Wells Journal: Dev Cell Date: 2009-07 Impact factor: 12.270